DeZwarteRidder schreef op 12 november 2020 08:26:
Financial highlights
Cash position–End of Q3 2020, Biocartis’ cash position amounted to EUR 137million(unaudited figure).
Extraordinary Shareholders’ Meeting–During the extraordinary shareholders’ meeting held on 25 September2020, the shareholders of the Company approved all agenda items, including
the renewal of the authorization to the Board of Directors to increase the share capital of the Company by up to 20% of the then current amount during a period of one year